Scancell
SEARCH
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • PARTNERSHIPS
    • CAREERS
  • VACCINES
    • MODITOPE
      • Modi-1
      • Modi-2
    • IMMUNOBODY
      • SCIB1 & iSCIB1+
      • SCIB2 & iSCIB2
      • COVIDITY
    • VACCINE PUBLICATIONS
  • ANTIBODIES
    • GLYMAB
      • ANTI-GLYCAN MAB
    • AVIDIMAB
    • ANTIBODY PUBLICATIONS
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2022
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US
SEARCH
  • NEWS
  • HOME
  • COMPANY
    • BOARD OF DIRECTORS
    • MANAGEMENT
    • PARTNERSHIPS
    • CAREERS
  • VACCINES
    • MODITOPE
      • Modi-1
      • Modi-2
    • IMMUNOBODY
      • SCIB1 & iSCIB1+
      • SCIB2 & iSCIB2
      • COVIDITY
    • VACCINE PUBLICATIONS
  • ANTIBODIES
    • GLYMAB
      • ANTI-GLYCAN MAB
    • AVIDIMAB
    • ANTIBODY PUBLICATIONS
  • INVESTORS
    • COMPANY PROFILE
    • ADVISORS
    • CORPORATE GOVERNANCE
    • DOCUMENTS & PRESENTATIONS
    • SHARE INFO
    • FINANCIAL INFO
    • 2020 CAPITAL RAISE
    • REGULATORY NEWS
    • REGULATORY NEWS ARCHIVE
  • NEWS
    • LATEST NEWS
    • INTERVIEWS
    • MEDIA COVERAGE
    • WEBCASTS
    • YEAR - 2022
    • YEAR - 2021
    • YEAR - 2020
    • YEAR - 2019
    • YEAR - 2018
    • YEAR - 2017
    • YEAR - 2016
    • YEAR - 2015
  • CONTACT US

News

Scancell announces UK regulatory approval to start SCIB1 Phase 2 trial in patients with advanced melanoma

To download click here

Thursday 25 April 2019 13:00 Categories: News Regulatory News SCIB1 Year - 2019

Scancell Holdings wins Japanese patent protection

It follows on from similar awards in key markets such as the US, Europe, South Africa and Australia

[View article]

Monday 8 April 2019 13:20 Categories: Immunobody Media Coverage SCIB1 SCIB2 Year - 2019

Scancell announces grant of Japanese patent that protects its Moditope immunotherapy programme

To download click here

Monday 8 April 2019 13:00 Categories: Moditope News Regulatory News Year - 2019

Professor Lindy Durrant receives Waldenström award from the Swedish Society of Oncology

To download click here

Thursday 21 March 2019 12:00 Categories: Moditope News Year - 2019

IP Portfolio Strengthened

To download click here

Wednesday 20 March 2019 12:00 Categories: Modi-1 Moditope News Regulatory News Year - 2019

Scancell strengthens IP with two “important” patent grants in US and Europe

The US patent covers Modi-1, while the European patent relates to a monoclonal antibody called FG88

[View article]

Wednesday 20 March 2019 11:55 Categories: Media Coverage Modi-1 Moditope Year - 2019

Holdings in Company

To download click here

Wednesday 6 March 2019 13:00 Categories: News Regulatory News Year - 2019

Change of Auditor

To download click here

Thursday 21 February 2019 13:00 Categories: News Regulatory News Year - 2019

Scancell in vanguard of immuno-oncology advances, with two technologies that show early promise

The AIM-listed group is at the vanguard of advances in the emerging field of immuno-oncology and is working on two technologies that are showing early promise

[View article]

Tuesday 12 February 2019 20:07 Categories: Immunobody Media Coverage Modi-1 Modi-2 SCIB1 SCIB2 Year - 2019

Scancell lauds another six months of progress

The funds raised in the last year "will allow us to focus on initiating the planned Phase 2 clinical trial for our lead ImmunoBody, SCIB1, and to advance our Moditope products, Modi-1 and Modi-2, towards the clinic".

[View article]

Thursday 31 January 2019 13:41 Categories: Immunobody Media Coverage Modi-1 Modi-2 Moditope SCIB1 Year - 2019
  • Page 10 of 36
  • 
  • 
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 20
  • 
  • 

Categories

  • AvidiMab (9)
  • Covid-19 (13)
  • GlyMab (1)
  • Immunobody (112)
  • Interviews (11)
  • Media Coverage (43)
  • Modi-1 (40)
  • Modi-2 (4)
  • Moditope (75)
  • News (306)
  • Presentations (6)
  • Regulatory News (273)
  • SCIB1 (135)
  • SCIB2 (22)
  • Webcasts (1)
  • Year - 2014 and older (142)
  • Year - 2015 (15)
  • Year - 2016 (31)
  • Year - 2017 (21)
  • Year - 2018 (42)
  • Year - 2019 (47)
  • Year - 2020 (30)
  • Year - 2021 (20)
  • Year - 2022 (5)
  • Company
  • Overview
  • Board of Directors
  • Management
  • Partnerships
  • Careers
  • Vaccines
  • Moditope
  • Immunobody
  • Vaccine Publications
  • Antibodies
  • GlyMAb
  • AvidiMab
  • Antibody Publications
  • Investors
  • Company Profile
  • Advisors
  • Corporate Governance
  • Documents & Presentations
  • Share Information
  • Financial Information
  • Regulatory News
  • News
  • Latest News
  • Contact Us
  • Privacy

News updates

Sign up for news updates to stay up to date with Scancell

Privacy & legal notes ©Copyright Scancell 2022